Oncology Medical News about high grade gliomas

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Recommendations on the use of 18F-FDG PET in oncology

3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials

4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer

5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Can permeability measurements add to blood volume measurements in differentiating tumefactive demyelinating lesions from high grade gliomas using perfusion CT
Journal of Neuro-Oncology, 10/30/09

Jain R et al. – TDLs show lower PS and CBV as compared to high grade gliomas, to which they can mimic on conventional MR imaging, due to lack of neoangiogenesis and vascular endothelial proliferation and hence perfusion CT can be used to differentiate the two entities.

<< Previous
Disease stabilization of progressive olfactory neuroblastoma...

Next >>
Association of serum levels of lipid and its novel constituents...

Treatment of recurrent high-grade gliomas
Current Opinion in Neurology, 11/12/09 Relevance Score: 82%

A Phase II Study of Cisplatin and Temozolomide in Heavily Pre-treated Patients with Temozolomide-refractory High-grade Malignant Glioma
Anticancer Research, 11/13/09 Relevance Score: 81%

Diagnostic Value of Proton Magnetic Resonance Spectroscopy in the Noninvasive Grading of Solid Gliomas: Comparison of Maximum and Mean Choline Values
Neurosurgery, 10/26/09 Relevance Score: 81%

Plasma IGFBP-2 levels predict clinical outcomes of patients with high-grade gliomas
Neuro-Oncology, 10/05/09 Relevance Score: 81%

Classification of brain tumor type and grade using MRI texture and shape in a machine learning scheme
Magnetic Resonance in Medicine, 11/17/09 Relevance Score: 80%